The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice
Abstract Respiratory syncytial virus (RSV)-bronchiolitis is a major cause of infant morbidity and mortality and a risk factor for subsequent asthma. We showed previously that toll-like receptor (TLR)7 in plasmacytoid dendritic cells (pDCs) is critical for protection against bronchiolitis and asthma...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16320a97d87d463db6bea7ee5c251f82 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:16320a97d87d463db6bea7ee5c251f82 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:16320a97d87d463db6bea7ee5c251f822021-12-02T12:32:42ZThe Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice10.1038/s41598-017-02564-92045-2322https://doaj.org/article/16320a97d87d463db6bea7ee5c251f822017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02564-9https://doaj.org/toc/2045-2322Abstract Respiratory syncytial virus (RSV)-bronchiolitis is a major cause of infant morbidity and mortality and a risk factor for subsequent asthma. We showed previously that toll-like receptor (TLR)7 in plasmacytoid dendritic cells (pDCs) is critical for protection against bronchiolitis and asthma in mice infected with pneumonia virus of mice (PVM), the mouse homolog of RSV. This lack of redundancy was unexpected as interferon-β promotor stimulator-1 (IPS-1) signalling, downstream of RIG-I-like receptor (RLR) and not TLR7 activation, contributes to host defence in hRSV-inoculated adult mice. To further clarify the role of IPS-1 signalling, we inoculated IPS-1−/− and WT mice with PVM in early-life, and again in later-life, to model the association between bronchiolitis and asthma. IPS-1 deficiency predisposed to severe PVM bronchiolitis, characterised by neutrophilic inflammation and necroptotic airway epithelial cell death, high mobility group box 1 (HMGB1) and IL-33 release, and downstream type-2 inflammation. Secondary infection induced an eosinophilic asthma-like pathophysiology in IPS-1−/− but not WT mice. Mechanistically, we identified that IPS-1 is necessary for pDC recruitment, IFN-α production and viral control. Our findings suggest that TLR7 and RLR signalling work collaboratively to optimally control the host response to pneumovirus infection thereby protecting against viral bronchiolitis and subsequent asthma.Jennifer SimpsonJason P. LynchZhixuan LohVivian ZhangRhiannon B. WerderKirsten SpannSimon PhippsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jennifer Simpson Jason P. Lynch Zhixuan Loh Vivian Zhang Rhiannon B. Werder Kirsten Spann Simon Phipps The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
description |
Abstract Respiratory syncytial virus (RSV)-bronchiolitis is a major cause of infant morbidity and mortality and a risk factor for subsequent asthma. We showed previously that toll-like receptor (TLR)7 in plasmacytoid dendritic cells (pDCs) is critical for protection against bronchiolitis and asthma in mice infected with pneumonia virus of mice (PVM), the mouse homolog of RSV. This lack of redundancy was unexpected as interferon-β promotor stimulator-1 (IPS-1) signalling, downstream of RIG-I-like receptor (RLR) and not TLR7 activation, contributes to host defence in hRSV-inoculated adult mice. To further clarify the role of IPS-1 signalling, we inoculated IPS-1−/− and WT mice with PVM in early-life, and again in later-life, to model the association between bronchiolitis and asthma. IPS-1 deficiency predisposed to severe PVM bronchiolitis, characterised by neutrophilic inflammation and necroptotic airway epithelial cell death, high mobility group box 1 (HMGB1) and IL-33 release, and downstream type-2 inflammation. Secondary infection induced an eosinophilic asthma-like pathophysiology in IPS-1−/− but not WT mice. Mechanistically, we identified that IPS-1 is necessary for pDC recruitment, IFN-α production and viral control. Our findings suggest that TLR7 and RLR signalling work collaboratively to optimally control the host response to pneumovirus infection thereby protecting against viral bronchiolitis and subsequent asthma. |
format |
article |
author |
Jennifer Simpson Jason P. Lynch Zhixuan Loh Vivian Zhang Rhiannon B. Werder Kirsten Spann Simon Phipps |
author_facet |
Jennifer Simpson Jason P. Lynch Zhixuan Loh Vivian Zhang Rhiannon B. Werder Kirsten Spann Simon Phipps |
author_sort |
Jennifer Simpson |
title |
The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
title_short |
The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
title_full |
The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
title_fullStr |
The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
title_full_unstemmed |
The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
title_sort |
absence of interferon-β promotor stimulator-1 (ips-1) predisposes to bronchiolitis and asthma-like pathology in response to pneumoviral infection in mice |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/16320a97d87d463db6bea7ee5c251f82 |
work_keys_str_mv |
AT jennifersimpson theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT jasonplynch theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT zhixuanloh theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT vivianzhang theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT rhiannonbwerder theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT kirstenspann theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT simonphipps theabsenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT jennifersimpson absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT jasonplynch absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT zhixuanloh absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT vivianzhang absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT rhiannonbwerder absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT kirstenspann absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice AT simonphipps absenceofinterferonbpromotorstimulator1ips1predisposestobronchiolitisandasthmalikepathologyinresponsetopneumoviralinfectioninmice |
_version_ |
1718393963440766976 |